Bivalirudin Crowned as Better Anticoagulant for Primary PCI in STEMI
Gregg Stone, MD, discusses why bivalirudin could be a preferred anticoagulant for patients undergoing primary percutaneous coronary intervention (PCI).
![Building exterior](/files/MSHealth/Assets/Global/Newsroom/2021/ISMMS-Spotlight-Placeholder-2col-770x420-2.jpg)
Press Release
Inter-Atrial Shunts May Benefit Some Heart Failure Patients While Harming Others
Apr 06, 2024 View All Press Releases![New York skyscraper seen from a park](/files/MSHealth/Assets/Global/Newsroom/2021/ISMMS-Spotlight-Placeholder-2col-770x420-4.jpg)
Press Release
New Treatment Approach for Advanced Coronary Artery Disease Leads to Improved Outcomes
Nov 04, 2021 View All Press Releases